Implantable cardioverter defibrillator management: an update

Papers of special note have been highlighted as: •• of considerable interest

References

• 1 Mendis SPP, Norrving B. Global atlas on cardiovascular disease prevention and control. WHO, Geneva, Switzerland (2011). www.world-heart-federation.org.
  Google Scholar
• 2 Priori SG, Blomström-Lundqvist C, Mazzanti A et al. Authors/Task Force Members; Document Reviewers. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur. Heart J. 36(41), 2793–2867 (2015). •• These are the European Guidelines and landmark on the subject.
  MedlineGoogle Scholar
• 3 Mozaffarian D, Benjamin EJ, Go AS et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation 133(4), e38–e360 (2016).
  MedlineGoogle Scholar
• 4 Cobb LA, Baum RS, Alvarez H III, Schaffer WA. Resuscitation from out-of-hospital ventricular fibrillation: 4 years follow-up. Circulation 52(Suppl. 6), III223–III235 (1975).
  Medline CASGoogle Scholar
• 5 Berdowski J, ten Haaf M, Tijssen JG, Chapman FW, Koster RW. Time in recurrent ventricular fibrillation and survival after out-of-hospital cardiac arrest. Circulation 122(11), 1101–1108 (2010).
  MedlineGoogle Scholar
• 6 Mirowski M, Reid PR, Mower MM et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N. Engl. J. Med. 303(6), 322–324 (1980).
  Medline CASGoogle Scholar
• 7 Trappe HJ. The “modern” implantable cardioverter-defibrillator: comparing it to those of the late 1980s. Am. J. Cardiol. 78(5A), 3–8 (1996).
  Medline CASGoogle Scholar
• 8 Hohnloser SH, Kuck KH, Dorian P et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N. Engl. J. Med. 351(24), 2481–2488 (2004).
  Medline CASGoogle Scholar
• 9 Steinbeck G, Andresen D, Seidl K et al. Defibrillator implantation early after myocardial infarction. N. Engl. J. Med. 361(15), 1427–1436 (2009).
  Medline CASGoogle Scholar
• 10 Elliott PM, Anastasakis A, Borger MA et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur. Heart J. 35(39), 2733–2779 (2014).
  MedlineGoogle Scholar
• 11 Holley LK. Development of device therapy for ventricular arrhythmias. Heart Lung Circ. 16(3), 162–169 (2007).
  MedlineGoogle Scholar
• 12 Sweeney MO. Antitachycardia pacing for ventricular tachycardia using implantable cardioverter defibrillators. Pacing Clin. Electrophysiol. 27(9), 1292–1305 (2004).
  MedlineGoogle Scholar
• 13 Wietholt D, Block M, Isbruch F et al. Clinical experience with antitachycardia pacing and improved detection algorithms in a new implantable cardioverter-defibrillator. J. Am. Coll. Cardiol. 21(4), 885–894 (1993).
  Medline CASGoogle Scholar
• 14 Swerdlow CD, Friedman PA. Advanced ICD troubleshooting: part I. Pacing Clin. Electrophysiol. 28(12), 1322–1346 (2005).
  MedlineGoogle Scholar
• 15 Poole JE, Johnson GW, Hellkamp AS et al. Prognostic importance of defibrillator shocks in patients with heart failure. N. Engl. J. Med. 359(10), 1009–1017 (2008).
  Medline CASGoogle Scholar
• 16 Ellenbogen KA, Kay GN, Lau C, Wilkoff BL. Clinical Cardiac Pacing, Defibrillation And Resynchronization Therapy (3rd Edition). Saunders, Elsevier Inc., Philadelphia, PA, USA (2007).
  Google Scholar
• 17 Migliore F, Curnis A, Bertaglia E. Axillary vein technique for pacemaker and implantable defibrillator leads implantation: a safe and alternative approach? J. Cardiovasc. Med. (Hagerstown) 17(4), 309–313 (2016).
  Medline CASGoogle Scholar
• 18 Kirkfeldt RE, Johansen JB, Nohr EA, Moller M, Arnsbo P, Nielsen JC. Pneumothorax in cardiac pacing: a population-based cohort study of 28,860 Danish patients. Europace 14(8), 1132–1138 (2012).
  MedlineGoogle Scholar
• 19 Blatt JA, Poole JE, Johnson GW et al. No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). J. Am. Coll. Cardiol. 52(7), 551–556 (2008).
  MedlineGoogle Scholar
• 20 Brignole M, Occhetta E, Bongiorni MG et al. Clinical evaluation of defibrillation testing in an unselected population of 2,120 consecutive patients undergoing first implantable cardioverter-defibrillator implant. J. Am. Coll. Cardiol. 60(11), 981–987 (2012).
  MedlineGoogle Scholar
• 21 Stavrakis S, Patel NH, Reynolds DW. Defibrillation threshold testing does not predict clinical outcomes during long-term follow-up: a meta-analysis. Pacing Clin. Electrophysiol. 36(11), 1402–1408 (2013).
  MedlineGoogle Scholar
• 22 Birnie D, Tung S, Simpson C et al. Complications associated with defibrillation threshold testing: the Canadian experience. Heart Rhythm 5(3), 387–390 (2008).
  MedlineGoogle Scholar
• 23 van Rees JB, Borleffs CJ, de Bie MK et al. Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality. J. Am. Coll. Cardiol. 57(5), 556–562 (2011).
  MedlineGoogle Scholar
• 24 Moss AJ, Schuger C, Beck CA et al. Reduction in inappropriate therapy and mortality through ICD programming. N. Engl. J. Med. 367(24), 2275–2283 (2012).
  Medline CASGoogle Scholar
• 25 Tan VH, Wilton SB, Kuriachan V, Sumner GL, Exner DV. Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis. Circ. Arrhythm. Electrophysiol. 7(1), 164–170 (2014).
  MedlineGoogle Scholar
• 26 Schaer B, Kühne M, Reichlin T, Osswald S, Sticherling C. Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication. Europace 18(2), 227–231 (2016).
  MedlineGoogle Scholar
• 27 Reynolds MR, Cohen DJ, Kugelmass AD et al. The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. J. Am. Coll. Cardiol. 47(12), 2493–2497 (2006).
  MedlineGoogle Scholar
• 28 Ezzat VA, Lee V, Ahsan S et al. A systematic review of ICD complications in randomised controlled trials versus registries: is our ‘real-world’ data an underestimation? Open Heart 2(1), e000198 (2015).
  MedlineGoogle Scholar
• 29 Kirkfeldt RE, Johansen JB, Nohr EA, Jørgensen OD, Nielsen JC. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur. Heart J. 35(18), 1186–1194 (2014).
  MedlineGoogle Scholar
• 30 Lee DS, Krahn AD, Healey JS et al. Evaluation of early complications related to De novo cardioverter defibrillator implantation insights from the Ontario ICD database. J. Am. Coll. Cardiol. 55(8), 774–782 (2010).
  MedlineGoogle Scholar
• 31 Pang BJ, Barold SS, Mond HG. Injury to the coronary arteries and related structures by implantation of cardiac implantable electronic devices. Europace 17(4), 524–529 (2015).
  MedlineGoogle Scholar
• 32 Kutinsky IB, Jarandilla R, Jewett M, Haines DE. Risk of hematoma complications after device implant in the clopidogrel era. Circ. Arrhythm. Electrophysiol. 3(4), 312–318 (2010).
  MedlineGoogle Scholar
• 33 van Rees JB, de Bie MK, Thijssen J, Borleffs CJ, Schalij MJ, van Erven L. Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials. J. Am. Coll. Cardiol. 58(10), 995–1000 (2011).
  MedlineGoogle Scholar
• 34 Buiten MS, De Bie MK, Van Der Heijden AC et al. Chronic kidney disease and implantable cardioverter defibrillator related complications: 16 years of experience. J. Cardiovasc. Electrophysiol. 25(9), 998–1004 (2014).
  MedlineGoogle Scholar
• 35 Birnie DH, Healey JS, Wells GA et al. Pacemaker or defibrillator surgery without interruption of anticoagulation. N. Engl. J. Med. 368(22), 2084–2093 (2013).
  Medline CASGoogle Scholar
• 36 Doughty DB. Preventing and managing surgical wound dehiscence. Adv. Skin Wound Care 18(6), 319–322 (2005).
  MedlineGoogle Scholar
• 37 Korantzopoulos P, Sideris S, Dilaveris P, Gatzoulis K, Goudevenos JA. Infection control in implantation of cardiac implantable electronic devices: current evidence, controversial points, and unresolved issues. Europace 18(4), 473–478 (2015).
  MedlineGoogle Scholar
• 38 Da Costa A, Kirkorian G, Cucherat M et al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation 97(18), 1796–1801 (1998).
  Medline CASGoogle Scholar
• 39 Bloom HL, Constantin L, Dan D et al. Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope. Pacing Clin. Electrophysiol. 34(2), 133–142 (2011).
  MedlineGoogle Scholar
• 40 Polyzos KA, Konstantelias AA, Falagas ME. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace 17(5), 767–777 (2015).
  MedlineGoogle Scholar
• 41 Magyar-Russell G, Thombs BD, Cai JX et al. The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review. J. Psychosom. Res. 71(4), 223–231 (2011).
  MedlineGoogle Scholar
• 42 Braunschweig F, Boriani G, Bauer A et al. Management of patients receiving implantable cardiac defibrillator shocks: recommendations for acute and long-term patient management. Europace 12(12), 1673–1690 (2010).
  MedlineGoogle Scholar
• 43 Starrenburg A, Pedersen S, van den Broek K, Kraaier K, Scholten M, Van der Palen J. Gender differences in psychological distress and quality of life in patients with an ICD 1 year postimplant. Pacing Clin. Electrophysiol. 37(7), 843–852 (2014).
  MedlineGoogle Scholar
• 44 van der Heijden AC, Borleffs CJ, Buiten MS et al. Clinical course of patients with implantable cardioverter-defibrillators: extended experience on clinical outcome, device replacements, and device-related complications. Heart Rhythm 12(6), 1169–1176 (2015).
  MedlineGoogle Scholar
• 45 Sabbag A, Suleiman M, Laish-Farkash A et al. Contemporary rates of appropriate shock therapy in patients who receive implantable device therapy in a real-world setting: from the Israeli ICD registry. Heart Rhythm 12(12), 2426–2433 (2015).
  MedlineGoogle Scholar
• 46 Singh SN, Poole J, Anderson J et al. Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure. Am. Heart J. 152(5), 974.e7–974.e11 (2006).
  Google Scholar
• 47 Sears SF, Todaro JF, Urizar G et al. Assessing the psychosocial impact of the ICD: a national survey of implantable cardioverter defibrillator health care provides. Pacing Clin. Electrophysiol. 23(6), 939–945 (2000).
  Medline CASGoogle Scholar
• 48 Rosenqvist M, Beyer T, Block M, den Dulk K, Minten J, Lindemans F. Adverse events in transvenous implantable cardioverter-defibrillators: a prospective multicenter study. European 7219 Jewel ICD investigators. Circulation 98(7), 663–670 (1998).
  Medline CASGoogle Scholar
• 49 Daubert JP, Zareba W, Cannom DS et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J. Am. Coll. Cardiol. 51(14), 1357–1365 (2008).
  MedlineGoogle Scholar
• 50 Shah H, Mezu U, Patel D et al. Mechanisms of inappropriate defibrillator therapy in a modern cohort of remotely monitored patients. Pacing Clin. Electrophysiol. 36(5), 547–552 (2013).
  MedlineGoogle Scholar
• 51 Hohnloser SH, Al-Khalidi HR, Pratt CM et al. Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial. Eur. Heart J. 27(24), 3027–3032 (2006).
  MedlineGoogle Scholar
• 52 Sesselberg HW, Moss AJ, McNitt S et al. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy. Heart Rhythm 4(11), 1395–1402 (2007).
  MedlineGoogle Scholar
• 53 Epstein AE, Dimarco JP, Ellenbogen KA et al. ACC/AHA/HRS 2008 Guidelines for devices-based therapy of cardiac rhythm abnormalites. Heart Rhythm 5(6), e1–e62 (2008).
  MedlineGoogle Scholar
• 54 Cronin EM, Varma N. Remote monitoring of cardiovascular implanted electronic devices: a paradigm shift for the 21th century. Expert Rev. Med. Devices 9(4), 367–376 (2012).
  Medline CASGoogle Scholar
• 55 Sørensen JT, Clommensen P, Sejersten M. Telecardiology: past, present and future. Rev. Esp. Cardiol. 66(3), 212–218 (2013).
  MedlineGoogle Scholar
• 56 Varma N, Epstein AE, Irimpen A, Schweikert R, Love C. TRUST Investigators. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation 122(4), 325–332 (2010).
  MedlineGoogle Scholar
• 57 Varma N, Michalski J, Epstein AE, Schweikert R. Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance: the Lumos-T Safely RedUceS RouTine Office Device Follow-Up (TRUST) trial. Circ. Arrhythm. Electrophysiol. 3(5), 428–436 (2010).
  MedlineGoogle Scholar
• 58 Martin DT, Bersohn MM, Waldo AL et al. Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices. Eur. Heart J. 36(26), 1660–1668 (2015).
  MedlineGoogle Scholar
• 59 Vollmann D, Nägele H, Schauerte P et al. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. Eur. Heart J. 28(15), 1835–1840 (2007).
  MedlineGoogle Scholar
• 60 Boriani G, Da Costa A, Ricci RP et al. The MOnitoring Resynchronization dEvices and CARdiac patiEnts (MORE-CARE) randomized controlled trial: Phase 1 results on dynamics of early intervention with remote monitoring. J. Med. Internet. Res. 15(8), e167 (2013).
  MedlineGoogle Scholar
• 61 Oliveira M, Cunha PS, Da Silva N. Remote monitoring for follow-up of patients with implantable cardiac device. Rev. Port. Cardiol. 32(3), 185–190 (2013).
  MedlineGoogle Scholar
• 62 Parekh PJ, Buerlein RC, Shams R, Herre J, Johnson DA. An update on the management of implanted cardiac devices during electrosurgical procedures. Gastrointest. Endosc. 78(6), 836–841 (2013).
  MedlineGoogle Scholar
• 63 Crossley GH, Poole JE, Rozner MA et al. The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management this document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Heart Rhythm 8(7), 1114–1154 (2011).
  MedlineGoogle Scholar
• 64 Nordbeck P, Ertl G, Ritter O. Magnetic resonance imaging safety in pacemaker and implantable cardioverter defibrillator patients: how far have we come? Eur. Heart J. 36(24), 1505–1511 (2015).
  MedlineGoogle Scholar
• 65 Petersen BT, Hussain N, Marine JE et al. Technology Assessment Committee. Endoscopy in patients with implanted electronic devices. Gastrointest. Endosc. 65(4), 561–568 (2007).
  MedlineGoogle Scholar
• 66 St. Jude Medical. Effect of endoscopy on St. Jude medical implantable cardiac rhythm devices. www.sjm.com/∼/media/pro.
  Google Scholar
• 67 Cuschieri JR, Osman MN, Wong RC, Chak A, Isenberg GA. Small bowel capsule endoscopy in patients with cardiac pacemakers and implantable cardioverter defibrillators: outcome analysis using telemetry review. World J. Gastrointest. Endosc. 4(3), 87–93 (2012).
  MedlineGoogle Scholar
• 68 Stanich PP, Kleinman B, Betkerur K, Mehta Oza N, Porter K, Meyer MM. Video capsule endoscopy is successful and effective in outpatients with implantable cardiac devices. Dig. Endosc. 26(6), 726–730 (2014).
  MedlineGoogle Scholar
• 69 Leighton JA, Sharma VK, Srivathsan K et al. Safety of capsule endoscopy in patients with pacemakers. Gastrointest. Endosc. 59(4), 567–569 (2004).
  MedlineGoogle Scholar
• 70 Harris LA, Hansel SL, Rajan E et al. Capsule endoscopy in patients with implantable electromedical devices is safe. Gastroenterol. Res. Pract. 2013, 959234 (2013).
  MedlineGoogle Scholar
• 71 Bandorski D, Höltgen R, Stunder D, Keuchel M. Capsule endoscopy in patients with cardiac pacemakers, implantable cardioverter defibrillators and left heart assist devices. Ann. Gastroenterol. 27(1), 3–8 (2014).
  MedlineGoogle Scholar
• 72 Magnani A, Balbo P, Facchini E, Occhetta E, Marino P. Lack of interference of electromagnetic navigation bronchoscopy to implanted cardioverter-defibrillator: in-vivo study. Europace 16(12), 1767–1771 (2014).
  MedlineGoogle Scholar
• 73 Zecchin M, Morea G, Severgnini M et al. Malfunction of cardiac devices after radiotherapy without direct exposure to ionizing radiation: mechanisms and experimental data. Europace 18(2), 288–293 (2016).
  MedlineGoogle Scholar
• 74 Hurkmans CW, Knegjens JL, Oei BS et al. Management of radiation oncology patients with a pacemaker or ICD: a new comprehensive practical guideline in The Netherlands. Dutch Society of Radiotherapy and Oncology (NVRO). Radiat. Oncol. 7, 198 (2012).
  MedlineGoogle Scholar
• 75 Borleffs CJ, van Erven L, van Bommel RJ et al. Risk of failure of transvenous implantable cardioverter-defibrillator leads. Circ. Arrhythm. Electrophysiol. 2(4), 411–416 (2009).
  MedlineGoogle Scholar
• 76 Lambiase PD, Barr C, Theuns DA et al. Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESSS-ICD Registry. Eur. Heart J. 35(25), 1657–1665 (2014).
  MedlineGoogle Scholar
• 77 Reddy VY, Exner DV, Cantillon DJ et al. Percutaneous implantation of an entirely intracardiac leadless pacemaker. N. Engl. J. Med. 373(12), 1125–1135 (2015).
  Medline CASGoogle Scholar
• 78 Reynolds D, Duray GZ, Omar R et al. A leadless intracardiac transcatheter pacing system. N. Engl. J. Med. 374(6), 533–541 (2016).
  Medline CASGoogle Scholar